secwatch.observer — SEC 8-K summary
======================================

Issuer:     CNS Pharmaceuticals, Inc. (CNSP)
CIK:        0001729427
Form:       8-K
Filed at:   2024-06-14T23:59:59+00:00
Accession:  0001683168-24-004253
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CNS Pharmaceuticals prices $1.37M registered direct offering and private placement
--------------------------------------------------------------------------------

- Offering of 366,000 shares (or pre-funded warrants) at $3.75/share, with common warrants exercisable at $3.62.
- Gross proceeds expected $1.37M; net proceeds for working capital and general corporate purposes.
- Closing expected on or about June 17, 2024, subject to customary closing conditions.
- Warrants expire 5 years from issuance; cashless exercise if no effective registration statement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1729427/000168316824004253/0001683168-24-004253-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1729427/000168316824004253/cns_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-24-004253

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer